ArticleInfection and immunity2026
Identification of novel pyrazolo[4,3-c]pyridine and diazepane derivatives as potent inhibitors of
Raunak Raunak, Aayush Bahl, Shubham Srivastava, Roopshali Rakshit, Shivani Bansal, Sashi Kant, Chandi C Mandal, Saurabh Pandey, Deeksha Tripathi
Abstract read
In one paragraphArticle in Infection and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Raunak Raunak *Microbial Pathogenesis and Microbiome Lab, Department of Microbiology, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India.
Aayush Bahl *Microbial Pathogenesis and Microbiome Lab, Department of Microbiology, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India.ORCID 0000-0002-1231-2568 Shubham SrivastavaDepartment of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Ajmer, Rajasthan, India.
Roopshali RakshitMicrobial Pathogenesis and Microbiome Lab, Department of Microbiology, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India.ORCID 0009-0003-4801-8285 Shivani BansalDepartment of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India.
Sashi KantDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Chandi C MandalDepartment of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India.
Saurabh PandeyDepartment of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, Delhi, India.
Deeksha TripathiMicrobial Pathogenesis and Microbiome Lab, Department of Microbiology, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India.ORCID 0000-0001-7059-5159 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Tuberculosis (TB), caused by
Indexed as
Antitubercular AgentsAzepinesBacterial ProteinsEnzyme InhibitorsMycobacterium tuberculosisProtein Tyrosine PhosphatasesPyrazolesPyridinesMolecular Docking SimulationMolecular Dynamics SimulationAntitubercular AgentsAzepinesBacterial ProteinsEnzyme InhibitorsProtein Tyrosine PhosphatasesPyrazolesPyridinesdrug discoveryinhibitorsmolecular dynamics simulationMycobacterium tuberculosisprotein tyrosine phosphatase Bpyrazolo[4,3-c] pyridine and diazepanetherapeutic
Identifiers
PMID41661129
PMCPMC12974134
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390